- Home
- OLMA vs VALN Comparison
OLMA vs VALN Comparison
Compare OLMA & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- VALN
- Stock Information
- Founded
- OLMA 2006
- VALN 2012
- Country
- OLMA United States
- VALN France
- Employees
- OLMA N/A
- VALN N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OLMA Health Care
- VALN Health Care
- Exchange
- OLMA Nasdaq
- VALN Nasdaq
- Market Cap
- OLMA 684.3M
- VALN 510.7M
- IPO Year
- OLMA 2020
- VALN 2021
- Fundamental
- Price
- OLMA $11.83
- VALN $7.00
- Analyst Decision
- OLMA Strong Buy
- VALN Strong Buy
- Analyst Count
- OLMA 5
- VALN 2
- Target Price
- OLMA $27.00
- VALN $21.50
- AVG Volume (30 Days)
- OLMA 537.3K
- VALN 10.3K
- Earning Date
- OLMA 11-05-2024
- VALN 08-13-2024
- Dividend Yield
- OLMA N/A
- VALN N/A
- EPS Growth
- OLMA N/A
- VALN N/A
- EPS
- OLMA N/A
- VALN N/A
- Revenue
- OLMA N/A
- VALN $167,655,631.00
- Revenue This Year
- OLMA N/A
- VALN $26.30
- Revenue Next Year
- OLMA N/A
- VALN $16.77
- P/E Ratio
- OLMA N/A
- VALN N/A
- Revenue Growth
- OLMA N/A
- VALN N/A
- 52 Week Low
- OLMA $8.51
- VALN $6.39
- 52 Week High
- OLMA $17.79
- VALN $14.94
- Technical
- Relative Strength Index (RSI)
- OLMA 45.05
- VALN 40.90
- Support Level
- OLMA $10.91
- VALN $7.57
- Resistance Level
- OLMA $12.70
- VALN $7.50
- Average True Range (ATR)
- OLMA 0.73
- VALN 0.34
- MACD
- OLMA 0.01
- VALN -0.09
- Stochastic Oscillator
- OLMA 51.40
- VALN 4.04
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.